Gene fusions involving the cytokine receptors CRLF2 and EPOR with IGH/IGK occur in approximately 6–14% of B-ALL diagnoses for older children, adolescents and adults and are associated with high-risk disease [22]. The gene discussed is CRLF2; the disease is precursor B-cell acute lymphoblastic leukemia.